Moving towards the implementation of pharmacogenetic testing in Quebec - Université d'Angers Accéder directement au contenu
Article Dans Une Revue Frontiers in Genetics Année : 2024

Moving towards the implementation of pharmacogenetic testing in Quebec

Ling Jing Li
  • Fonction : Auteur
Ann-Lorie Gagnon
  • Fonction : Auteur
Marie-Pier Frigon
  • Fonction : Auteur
Laurence Tessier
  • Fonction : Auteur
Karine Tremblay
  • Fonction : Auteur

Résumé

Clinical implementation of pharmacogenetics (PGx) into routine care will elevate the current paradigm of treatment decisions. However, while PGx tests are increasingly becoming reliable and affordable, several barriers have limited their widespread usage in Canada. Globally, over ninety successful PGx implementors can serve as models. The purpose of this paper is to outline the PGx implementation barriers documented in Quebec (Canada) to suggest efficient solutions based on existing PGx clinics and propose an adapted clinical implementation model. We conclude that the province of Quebec is ready to implement PGx.
Fichier principal
Vignette du fichier
Li_2024_moving towards the implementation of pharmacogenetic testing in Quebec.pdf (894.15 Ko) Télécharger le fichier
Origine : Fichiers éditeurs autorisés sur une archive ouverte

Dates et versions

hal-04403213 , version 1 (01-02-2024)

Licence

Paternité

Identifiants

Citer

Ling Jing Li, Samuel Legeay, Ann-Lorie Gagnon, Marie-Pier Frigon, Laurence Tessier, et al.. Moving towards the implementation of pharmacogenetic testing in Quebec. Frontiers in Genetics, 2024, 14, ⟨10.3389/fgene.2023.1295963⟩. ⟨hal-04403213⟩
15 Consultations
2 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More